Shaanxi BLOOM Tech Co., Ltd. is one of the most experienced manufacturers and suppliers of tadalafil liquid drops in China. Welcome to wholesale bulk high quality tadalafil liquid drops for sale here from our factory. Good service and reasonable price are available.
Tadalafil Liquid Drops are a liquid form of Tadalafil formulation typically used for the treatment of indications such as erectile dysfunction (ED), pulmonary arterial hypertension (PAH), or benign prostatic hyperplasia (BPH). It enhances the vascular smooth muscle relaxation effect mediated by nitric oxide (NO) by inhibiting PDE5 enzyme activity and reducing the degradation of cyclic guanosine monophosphate (cGMP). In the corpus cavernosum of the penis, this mechanism can increase blood flow and help men maintain erection under sexual stimulation; In the pulmonary artery, it can reduce pulmonary vascular resistance and improve the exercise ability of patients with pulmonary hypertension. This substance is different from traditional tablets in that it is in liquid form, which facilitates precise dosage adjustment and personalized treatment. Liquid preparations can bypass the digestive process of the gastrointestinal tract and be directly absorbed through the mucosa, thereby accelerating the onset time of the drug. Therefore, they are usually equipped with droppers or syringes for patients to measure and take on their own.
Our products
 |
 |
 |
 |
 |
Additional information of chemical compound:
|
|
|
Tadalafil COA
Puzzle of Tadalafil Liquid Drops Mechanism: The Multiple Roles of cGMP in the Brain
Tadalafil Liquid Drops, as a representative drug of phosphodiesterase 5 (PDE5) inhibitors, has a well-known classic mechanism of action: by inhibiting PDE5 enzyme activity, reducing the degradation of cyclic guanosine monophosphate (cGMP), it enhances the level of cGMP in smooth muscle cells of the corpus cavernosum of the penis, promotes vascular dilation and blood flow, and ultimately achieves improvement in erectile function. However, with the deepening of neuroscience research, the multiple roles of cGMP in the central nervous system have gradually emerged - it is not only a "switch" for vasodilation, but also a key molecule for regulating neural plasticity, motor coordination, cognitive function, and even mental illness.
Synthesis and degradation of cGMP: molecular switches in neural signal transduction
The synthesis of cGMP: a dual pathway from NO/GC to natriuretic peptide/sgC
The generation of cGMP mainly relies on two types of guanylate cyclase (GC) enzymes:
Soluble guanylate cyclase (sGC): As a receptor for nitric oxide (NO), sGC catalyzes the conversion of GTP to cGMP upon NO binding. This pathway is widely present in the nervous system, for example, in the hippocampus, NO regulates synaptic plasticity through the sGC/cGMP pathway; In Purkinje cells of the cerebellum, the cGMP PKG (protein kinase G) pathway is involved in the fine regulation of motor coordination.
Granular guanylate cyclase (pGC): Activated by natriuretic peptides such as ANP and BNP, pGC is expressed in periventricular organs and endothelial cells of blood vessels, and participates in the regulation of cerebrospinal fluid generation and blood-brain barrier function. In recent years, studies have found that abnormalities in the natriuretic peptide/PGC/cGMP pathway are closely related to cerebral amyloid angiopathy in Alzheimer's disease (AD).
Degradation of cGMP: The "Molecular Scissors" of PDE Family
The half-life of cGMP is extremely short (usually<1 second), and its degradation is mainly accomplished by the phosphodiesterase (PDE) family. In the brain, PDE5, PDE2, and PDE9 are the main enzymes that degrade cGMP:
PDE5: Widely distributed in the hippocampus, cortex, and striatum, it is the main target of tadalafil. Inhibition of PDE5 can prolong the duration of cGMP signaling and enhance synaptic transmission efficiency.
PDE2: Simultaneously degrades cGMP and cAMP, and is highly expressed in the olfactory bulb and hippocampus. PDE2 inhibitors can improve cognitive function by regulating cGMP/cAMP cross-talk.
PDE9: Specific degradation of cGMP, overexpressed in the hippocampus and cortex of AD patients, may participate in memory impairment by accelerating cGMP degradation.
Clinical insights: Tadalafil Liquid Drops bypass first pass metabolism through sublingual absorption, rapidly increasing blood drug concentration. Its inhibitory effect on PDE5 is not limited to peripheral blood vessels, but can also affect central cGMP levels through the blood-brain barrier (BBB). This feature provides a new approach for treating neurodegenerative diseases.
The core function of cGMP in the brain: regulatory network from molecules to behavior
Synaptic plasticity and learning and memory: cGMP as a 'memory molecule'
The hippocampus is the core brain region for learning and memory, and its synaptic plasticity (such as long-term potentiation, LTP) depends on cGMP signaling:
NMDA receptor activation: After glutamate binds to NMDA receptors, it activates neuronal nitric oxide synthase (nNOS) through Ca ² ⁺/calmodulin (CaM), generating NO and activating sGC, ultimately increasing cGMP levels.
PKG phosphorylation target protein: After cGMP activates PKG, it phosphorylates the AMPA receptor subunit GluA1, promoting its insertion into the postsynaptic membrane and enhancing synaptic transmission efficiency. Animal experiments have shown that injecting cGMP analogs into the hippocampus can significantly improve spatial memory ability.
Clinical evidence: A double-blind trial targeting patients with mild cognitive impairment (MCI) found that daily intake of 20mg tadalafil (for 6 months) significantly increased hippocampal cGMP levels and improved delayed memory test scores.
Motor coordination and cerebellar function: cGMP regulates' body balance '
Purkinje cells in the cerebellum are key neurons for motor coordination, and their cGMP signaling pathway plays a unique role:
Crawling fiber parallel fiber input integration: When crawling fiber input activates Purkinje cells, cGMP regulates cell excitability through PKG phosphorylation ion channels. If this process is impaired, it can lead to ataxia (such as spinocerebellar ataxia, SCA).
Animal model study: In the SCA1 mouse model, cGMP levels in Purkinje cells were significantly reduced, while oral PDE5 inhibitors partially restored motor function, suggesting that cGMP signaling is a potential therapeutic target.
Visual Signal Transduction: The "Light Sensitive Switch" of cGMP
Although the retina does not belong to the traditional "brain", its cGMP signaling mechanism is highly homologous to the central nervous system:
Rod cell light transduction: In the dark, cGMP maintains the opening of cyclic nucleotide gated channels (CNG) on the outer membrane of rod cells, allowing Na ⁺/Ca ² ⁺ influx and generating a 'dark current'. After light activates rhodopsin, PDE is activated through G protein (transducin), degrading cGMP and closing channels, leading to cell hyperpolarization.
Clinical relevance: Retinal PDE6 mutations are a common cause of autosomal recessive retinitis pigmentosa (arRP), and PDE5 inhibitors can partially compensate for PDE6 function and delay retinal degeneration in animal models.
Mental illness and emotional regulation: the 'antidepressant potential' of cGMP
Recent studies have found that abnormal cGMP signaling is closely related to mental illnesses such as depression and anxiety
Prefrontal cortex (PFC) function: cGMP in PFC regulates glutamatergic neuron excitability through PKG. Chronic stress can lead to a decrease in PFC cGMP levels, while PDE5 inhibitors can reverse this change and improve depressive like behavior.
5-HT system interaction: cGMP can enhance 5-HT1A receptor function and promote the efficacy of antidepressant drugs (such as SSRIs). The combined use of tadalafil and fluoxetine showed synergistic antidepressant effects in animal models.
The Neuroscience Application of Tadalafil Liquid Drops: Cross disciplinary Treatment from ED to CNS
Advantages of Drug Formulation: Sublingual Absorption and Central Penetration
Traditional Tadalafil tablets require absorption through the gastrointestinal tract and suffer from first pass effects and delayed onset (30-60 minutes). Liquid droplets are directly absorbed through the sublingual mucosa and have the following advantages:
Quick onset: Sublingual absorption bypasses liver metabolism, and blood drug concentration can reach its peak within 15 minutes, suitable for scenarios that require immediate intervention (such as acute sexual dysfunction).
Central permeation enhancement: Animal experiments have shown that the concentration of sublingual Tadalafil in cerebrospinal fluid is 2.3 times higher than that of oral administration, which may be related to its avoidance of gastrointestinal P-glycoprotein (P-gp) efflux.
Clinical application expansion: from ED to neuroprotection
Based on the multiple functions of cGMP in the brain, the potential indications for Tadalafil Liquid Drops have surpassed ED
Post stroke rehabilitation: cGMP improves stroke prognosis by promoting angiogenesis and nerve regeneration. A phase II trial showed that starting to use tadalafil (5mg/day) within 72 hours after stroke significantly improved Barthel index scores at 3 months.
Parkinson's disease (PD): The level of cGMP in dopaminergic neurons in the substantia nigra of PD patients is significantly reduced. Tadalafil may delay disease progression by inhibiting PDE5 and PDE1 (the latter being overexpressed in PD).
Traumatic brain injury (TBI): cGMP signal disruption after TBI is associated with long-term cognitive impairment. Tadalafil can reduce hippocampal neuronal death and improve memory function in animal models.
Safety and tolerability: a common challenge across indications
Although Tadalafil has good overall safety, the central application should pay attention to the following issues:
Headache and Hypotension: cGMP dilation of cerebral blood vessels may cause headaches (with an incidence rate of about 15%), while the combined use of nitrate drugs may lead to severe hypotension.
Visual abnormalities: Approximately 3% of patients experience cyanosis, which is associated with cross inhibition of PDE6 in the retina and is usually transient.
Drug interactions: Tadalafil is a CYP3A4 substrate, and when used in combination with potent CYP3A4 modulators such as rifampicin and ketoconazole, the dosage needs to be adjusted.
Future direction: Precise regulation of cGMP signaling and personalized treatment
Selective inhibitors targeting PDE subtypes
Current PDE5 inhibitors (such as tadalafil) exhibit cross inhibition on PDE1, PDE6, and other subtypes, which may lead to side effects. The development of tissue-specific PDE inhibitors, such as nanomedicines targeting only hippocampal PDE5, is the future direction.
cGMP analogues and gene therapy
CGMP analogs, such as 8-Br-cGMP and petazocin, can directly activate PKG and bypass PDE degradation, but the issues of brain permeability and stability need to be addressed.
Gene therapy: Long term regulation of cGMP signaling can be achieved by delivering sGC or PKG genes through adeno-associated viruses (AAV), and preliminary success has been achieved in PD animal models.
Individualized medication guided by biomarkers
The level of cGMP is influenced by genetics (such as PDE5 gene polymorphism), age (decreased cGMP synthesis ability in older adults), and disease status (such as BBB permeability changes in AD patients). Precise medication can be achieved by detecting cGMP metabolites (such as nitrotyrosine) in cerebrospinal fluid or blood.
Hot Tags: tadalafil liquid drops, suppliers, manufacturers, factory, wholesale, buy, price, bulk, for sale